The German group has come late to antibody testing, but has punchy accuracy data and a possible means of neutralising some of the competition.
Covid-19 could mean Medtronic loses out to Abbott, its rival in the mitral valve space.
With the prevalence of coronavirus infection running at about 5%, test manufacturers and regulators alike will have to guard against false positives.
The FDA is loosening its rules on the authorisation of diagnostic tests for the new coronavirus, but it is still some way behind Europe.
The good times continue to roll for big cap device makers, with two companies doubling their market value, and not a single share price fall.
The Dutch group is ripe for a takeover, and while Thermo Fisher has to be the likeliest candidate for acquirer there are a number of potentially interested parties.
Two dental companies go public inside a week, with very different results.
Deal is the fifth largest robotics surgery purchase ever, and the second big move from Stryker.
Intuitive Surgical makes the most money per employee – but the title of “most improved” goes to Philips.